EUVIMEDEUVIMED entdecken
Vergleichsstudie

Implantable Cardioverter Defibrillator in Nonischemic Versus Ischemic Cardiomyopathy: Real‐World Primary Prevention Study

Fankun Ma iD, Yang Gao, Haibo Yu iD, Guoqing Xu, Min Wu, Xinrui Hao, Yangfan Cui, Xiao Peng, Yanchun Liang iD

Pacing and Clinical Electrophysiology · 2025

DOI: 10.1111/pace.15142 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pacing and Clinical Electrophysiology, 2025. Verfasst von Fankun Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, People's Republic of China. Hauptthemen laut MEDLINE: Defibrillators, Implantable, Cardiomyopathies, Death, Sudden, Cardiac, Primary Prevention. Die Arbeit nennt 23 Literaturangaben. Gefördert von: the National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The evidence in the primary prevention of sudden cardiac death (SCD) by using implantable cardioverter defibrillators (ICD) in patients with ischemic cardiomyopathy (ICM) is well‐established but remains controversial for those with nonischemic cardiomyopathy (NICM). This study evaluates whether prognostic differences exist between ICM and NICM patients after ICD implantation.

Methods

Patients initially undergoing ICD implantation as primary SCD prevention were retrospectively enrolled from January 2017 to May 2023. Malignant ventricular arrhythmic and/or SCD were set as the primary endpoint, whereas all‐cause mortality was the secondary endpoint. Patients were grouped by heart failure etiology (ICM vs. NICM) and then by primary endpoint events occurrence. Outcomes analyses were performed between the NICM and ICM patients.

Results

The final cohort had 342 patients, 213 (62.3%) with NICM and 129 (37.7%) with ICM. At a median follow‐up of 23.0 (10.7, 33.2) months, 51 patients (14.9%) encountered primary endpoint events. No statistically significant disparities in primary endpoint events (log rank p = 0.413), all‐cause death (log rank p = 0.208), cardiovascular mortality (log rank p = 0.218), or appropriate ICD therapy (log rank p = 0.250) between the two groups were indicated by Kaplan–Meier survival analysis. Moreover, the COX‐adjusted models further demonstrated the absence of any significant differences between the two groups.

Conclusion

In real‐world settings, primary prevention of SCD with ICD implantation yields similar outcomes for ICM and NICM patients, including probabilities of SCD and/or malignant ventricular arrhythmias, all‐cause mortality, appropriate ICD therapy, and cardiovascular mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Defibrillators, ImplantableCardiomyopathiesDeath, Sudden, CardiacPrimary PreventionMyocardial IschemiaHumansMaleFemaleRetrospective StudiesMiddle AgedAged

Stichwörter der Autor:innen

implantable cardioverter defibrillatorischemic cardiomyopathynonischemic cardiomyopathyprimary prevention

Autor:innen und Institutionen

  • Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, People's Republic of China.

ORCID-Profile: Fankun Ma, Haibo Yu, Yanchun Liang

Förderung

  • the National Key Research and Development Program of China

Zitieren

APA

Ma, F., Gao, Y., Yu, H., Xu, G., Wu, M., Hao, X., Cui, Y., Peng, X., & Liang, Y. (2025). Implantable Cardioverter Defibrillator in Nonischemic Versus Ischemic Cardiomyopathy: Real‐World Primary Prevention Study. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.15142

Vancouver

Ma F, Gao Y, Yu H, Xu G, Wu M, Hao X, et al. Implantable Cardioverter Defibrillator in Nonischemic Versus Ischemic Cardiomyopathy: Real‐World Primary Prevention Study. Pacing and Clinical Electrophysiology. 2025. doi:10.1111/pace.15142

BibTeX
@article{Ma2025,
  author = {Ma, Fankun and Gao, Yang and Yu, Haibo and Xu, Guoqing and Wu, Min and Hao, Xinrui and Cui, Yangfan and Peng, Xiao and Liang, Yanchun},
  title = {Implantable Cardioverter Defibrillator in Nonischemic Versus Ischemic Cardiomyopathy: Real‐World Primary Prevention Study},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2025},
  doi = {10.1111/pace.15142}
}
Kostenlos starten →